Showing results 1 to 4 of 4
A novel imidazopyridine derivative, HS-106, induces apoptosis of breast cancer cells and represses angiogenesis by targeting the PI3K/mTOR pathway Li, Guang-Yong; Jung, Kyung Hee; Lee, Hyunseung; Son, Mi Kwon; Seo, JuHyeon; Hong, Sang-Won; Jeong, Yujeong; et al, CANCER LETTERS, v.329, no.1, pp.59 - 67, 2013-02 |
A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques Jung, Kyung Hee; Ryu, Ye-Lim; Lee, Hee-Seung; Lee, Hyunseung; Son, Mi Kwon; Yan, Hong Hua; Hong, Sang-Won; et al, INTERNATIONAL JOURNAL OF ONCOLOGY, v.42, no.6, pp.2001 - 2008, 2013-06 |
HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway Jung, Kyung Hee; Choi, Myung-Joo; Hong, Seunghee; Lee, Hyunseung; Hong, Sang-Won; Zheng, Hong-Mei; Lee, Hee-Seung; et al, CANCER LETTERS, v.316, no.2, pp.187 - 195, 2012-03 |
Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor Jung, Kyung Hee; Zheng, Hong-Mei; Jeong, Yujeong; Choi, Myung-Joo; Lee, Hyunseung; Hong, Sang-Won; Lee, Hee-Seung; et al, CANCER LETTERS, v.328, no.1, pp.176 - 187, 2013-01 |
Discover